Brands & Services
CRO services
Data collection
Independant committees
Market Access & HEOR
Medicine acceptability
Quality assurance
Safety reporting
Statistics & Medical writing
About us
Meet our team
History & values
ClinSearch News
Privacy Policy

Connect with us

About us

ClinSearch is a French Clinical Research Organization which provides clinical development and commercialization services for medical device and drug development on a European level. We are committed to offering individualized, cost-effective solutions to managing your pre- or post-marketing study in Europe, as well as obtaining reimbursement in key markets.
From developing study methodology, to writing and reviewing study documents, conducting regulatory and site feasibility, adapted electronic data management solutions, monitoring in Europe, producing top-notch study and statistical reports: we have it all under our roof in Malakoff, South-West Paris.
We have been serving the pharmaceutical and medical device industry since 1999, earning a reputation for delivering practical, measurable and high added-value data.

A proud employer of 20 nationalities, with uncompromising focus on regulatory compliance and best industry practices, we are able to pull our agile team of cross-functional experts to overcome any challenge in the clinical development or reimbursement process. Our promise is to always give you realistic advice, brainstorm the best solutions for you, and stand behind our word in terms of timelines and budgeting. Our services are always evolving, recently branching out more into digital solutions for accelerated recruitment and the procurement of superior clinical and reimbursement data.

Our team

Cécile Train

Senior Director
Medical Device & Drug Development

Petra Ulm

Global Reg. Affairs Director,
Data Protection Officer

Thibault Bogniaho

IS & IT Director,
Chief Information Security Officer

Saannya Sequiera

Scientific Advisory
Group Coordinator

ClinSearch News

“[...] in a clinical trial, imaging process variability may result in increased variability in endpoint measurements and may compromise the ability of the trial to achieve its objectives.”

Upgrading Management for DMC/DSMB and Core Labs in Clinical Trials

Meet us

8—11, 2021

12th PBP
World Meeting

Vienna, Austria